Antipsychotics (Segars) Flashcards

1
Q

Specific indication Clozapine

A

recurrent suicidal behavior

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

specific indication Pimavanserin

A

hallucinations/delusions associated with parkinsons disease psychosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Dopamine pathway responsible for positive symptoms of schizophrenia

A

overactivity of the mesolimbic pathway

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

dopamine pathway responsible for the negative and cognitive symptoms of schizophrenia

A

mesocortical pathway dysfunction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

positive symptoms of schizophrenia (5)

A
  • hallucinations
  • delusions
  • disorganized speech/thinking
  • agitation
  • abnormal motor behavior
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

negative symptoms of schizophrenia (5)

A
  • apathy
  • avolition
  • alogia
  • cognitive deficits (working memory)
  • social withdrawal
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

primary difference between first generation and second generation antipsychotics

A

reduced movement disorder side effects in second generation agents

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

receptors blocked by first generation antipsychotics (4)

A

1) primarily D2 post-synaptic receptors
2) Muscarinic
3) H1 receptors
4) alpha-1 receptors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

first generation anti-psychotics low potency agents (2)

A

1) thioridazine

2) chlorpromazine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

first generation anti-psychotics high potency agents (2)

A

1) fluphenazine

2) haloperidol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

first generation anti-psychotics low potency agent side effects

A

more sedation, hypotension and seizure-threshold reduction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

first generation anti-psychotics high potency agent side effects

A

more movement (EPS) and endocrine effects (prolactin)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

treatments for extrapyramidal symptoms (EPS) (2)

A

1) anticholinergic agents (benztropine and trihexyphenidyl)

2) antihistamine agents (diphenhydramine)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

treatments for tardive dyskinesia

A

selective vesicular monoamine transporter 2 (VMAT2) inhibitors:

1) valbenazine
2) deutetrabenazine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

suffix of VMAT2 inhibitors

A
  • benazine
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Second generation antipsychotics MOA (general)

A

stronger 5HT-2A receptor blockers than D2 receptor blockers

17
Q

Suffix second generation antipsychotics that are 5HT-2A/DA receptor antagonists

18
Q

Suffix second generation antipsychotics that are partial DA/5HT-1A receptor agonists

19
Q

Suffix second generation antipsychotics that are multi-acting receptor-target agents

20
Q

second generation antipsychotic that is an inverse serotonin agonist/antagonist

A

Pimavanserin (for parkinsons psychosis)

21
Q

MOA Cariprazine (2)

A

1) 5HT-2A/DA receptor antagonist

2) partial DA/5HT-1A receptor agonist

22
Q

Main side effects second generation antipsychotics

A

metabolic effects/weight gain

23
Q

What second generation antipsychotic causes agranulocytosis rarely? How is this monitored?

A

Clozapine; monitor WBC and enroll in REMS program

24
Q

What is a rare side effect of Olanzapine

A

drug reaction with eosinophilia and systemic symptoms (DRESS)

25
treatment for neuroleptic malignant syndrome
Dantrolene
26
What should be monitored for patients taking second generation antipsychotics
- serum glucose - lipids - weight - blood pressure - waist circumference
27
what is critical to treatment of psychotic disorders?
ADHERENCE
28
How can treatment non-adherence be managed?
Long-Acting Injectable Agents (LAIAs)
29
First generation LAIAs (2)
1) haloperidol decanoate | 2) fluphenazine decanoate
30
Second generation LAIAs (4)
1) Risperidone 2) Olanzapine 3) Aripiprazole lauroxil 4) Paliperidone palmitate (ROAP)